No. of death (%) | Hazard ratios and 95% confidence intervals‡ | |||
---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||
All-cause mortality | ||||
Categorical serum 25(OH)D concentration | ||||
Severe deficiency | 18 (9.0) | 0.87 (0.41–1.88) | 2.58 (1.31–5.05) | 2.83 (1.46–5.52) |
Moderate deficiency | 82 (6.6) | 0.63 (0.38–1.04) | 1.11 (0.68–1.82) | 1.17 (0.74–1.86) |
Insufficient | 122 (7.2) | 0.80 (0.50–1.26) | 1.30 (0.89–1.88) | 1.36 (0.93–1.98) |
Sufficient | 113 (9.4) | 1 (Ref) | 1 (Ref) | 1 (Ref) |
Continuous serum 25(OH)D concentration, per 10 nmol/L increase | 1.04 (0.98–1.10) | 0.92 (0.86–0.98) | 0.91 (0.85–0.97) | |
CVD mortality | ||||
Categorical serum 25(OH)D | ||||
Severe deficiency | 6 (3.0) | 0.49 (0.09–2.63) | 3.10 (0.87–11.05) | 4.14 (1.10–15.51) |
Moderate deficiency | 18 (1.5) | 0.49 (0.13–0.82) | 1.22 (0.44–3.39) | 1.23 (0.46–3.28) |
Insufficient | 34 (2.0) | 0.78 (0.25–2.49) | 1.53 (0.83–2.80) | 1.73 (0.96–3.14) |
Sufficient | 30 (2.5) | 1 (Ref) | 1 (Ref) | 1 (Ref) |
Continuous serum 25(OH)D, per 10 nmol/L increase | 1.07 (0.94–1.21) | 0.87 (0.76–0.98) | 0.86 (0.76–0.98) |